Conference Proceedings

A Phase 1, First-in-Human Study of AMG 176, a Selective MCL-1 Inhibitor, in Patients With Relapsed or Refractory Multiple Myeloma

Andrew Spencer, Aaron Seth Rosenberg, Andrzej Jakubowiak, Noopur Raje, Manik Chatterjee, Suzanne Trudel, Nizar J Bahlis, David S Siegel, Stefan Wilop, Simon J Harrison, Murthy NagaKrishna, Shyeilla Dhuria, Antreas Hindoyan, Zach McIver, Haby Henary, Phuong Khanh Morrow, Andrew Roberts

Clinical Lymphoma Myeloma & Leukemia | CIG MEDIA GROUP, LP | Published : 2019